The immunogenicity of influenza vaccine was recently investigated in 27 patients with systemic-onset juvenile idiopathic arthritis receiving tocilizumab, an anti-interleukin-6 receptor antibody. Here, IL6R is linked to juvenile idiopathic arthritis.